A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL)-Reference-Cited by-同舟云学术

A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL)

Published:2007-02 Issue:2 Volume:29 Page:305-315
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Tytus Richard H.,Burgess Ellen D.,Assouline Linda,Vanjaka Anita

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference32 articles.

1. Distribution of blood pressure and hypertension in Canada and the United States;Joffres;Am J Hypertens,2001

2. Midlife cardiovascular risk factors and risk of dementia in late life;Whitmer;Neurology,2005

3. Predictive power of cardiovascular risk factors for detecting peripheral vascular disease;Fine;South Med J,2004

4. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men;Neaton;Arch Intern Med,1992

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transforming Non-Selective Angiotensin-Converting Enzyme Inhibitors in C- and N-domain Selective Inhibitors by Using Computational Tools;Mini-Reviews in Medicinal Chemistry;2020-09-01

2. Pharmacokinetics, Pharmacodynamics, and Tolerability of Single and Multiple Doses of Trandolapril, an Effective Angiotensin-Converting Enzyme Inhibitor, in Healthy Chinese Subjects;European Journal of Drug Metabolism and Pharmacokinetics;2015-04-12

3. Drugs Targeting RAAS in the Treatment of Hypertension and Other Cardiovascular Diseases;Pathophysiology and Pharmacotherapy of Cardiovascular Disease;2015

4. Effectiveness and Tolerability of a Trandolapril-Based Antihypertensive Treatment Regimen over 12 months in Actual Clinical Care Across Canada;Clinical Drug Investigation;2013-06-20

5. Blood pressure control rates with an antihypertensive regimen including trandolapril in a canadian usual-care setting;Advances in Therapy;2011-08-16